Trevena's Intravenous Opioid Will Face Difficult US FDA Advisory Committee

Oliceridine is not superior to morphine, has abuse potential similar to other mu opioid agonists, FDA concludes; also endpoint Trevena used to evaluate respiratory safety was inadequate, FDA says.